11-Oxyandrogens in Adolescents With Polycystic Ovary Syndrome

• Published in: Journal of the Endocrine Society Vol. 6; no. 7; p. bvac037
• Main Authors: Taylor, Anya E, Ware, Meredith A, Breslow, Emily, Pyle, Laura, Severn, Cameron, Nadeau, Kristen J, Chan, Christine L, Kelsey, Megan M, Cree-Green, Melanie
• Format: Journal Article
• Language: English
• Published: US Oxford University Press 01-07-2022
• Subjects: Clinical; Comorbidity; Comparative analysis; Contraceptives; Dehydroepiandrosterone; Dextrose; Glucose; Glucose metabolism; Glycosylated hemoglobin; Insulin; Insulin resistance; Liquid chromatography; Low density lipoproteins; Mass spectrometry; Medical research; Medicine, Experimental; Obesity in adolescence; Physiological aspects; Puberty; Stein-Leventhal syndrome; Teenage girls; Testosterone; Colorado; adolescents; 11-oxyandrogens; polycystic ovary syndrome
• ISSN: 2472-1972; 2472-1972
• DOI: 10.1210/jendso/bvac037

Abstract
Context
Polycystic ovary syndrome (PCOS) is common and diagnosis requires an elevated testosterone. The clinical importance of adrenal 11-oxyandrogens in PCOS is unclear.
Objective
We sought to determine if 11-oxyandrogens 1) better identify PCOS diagnosis compared to testosterone, 2) predict clinical comorbidities of PCOS, and 3) are altered with an combined oral contraceptive pill (COCP) or metformin therapy.
Methods
Data from 200 adolescent female participants aged 12 to 21 years, most with obesity, enrolled across 6 studies in pediatric endocrinology were included: 70 non-PCOS controls, 115 untreated PCOS, 9 PCOS + obesity treated with COCP, and 6 PCOS + obesity treated with metformin. 11-Hydroxyandrostenedione (11-OHA4), 11-hydroxytestosterone (1-OHT), 11-ketotestosterone (11-KT), and testosterone were measured with liquid chromatography–tandem mass spectrometry. Data between 1) untreated PCOS and controls and 2) untreated PCOS and the 2 treatment groups were compared.
Results
Untreated girls with PCOS had higher 11-OHA4 (P = .003) and 11-OHT (P = .005) compared to controls, but not 11-KT (P = .745). Elevated 11-OHA4 remained statistically significant after controlling for obesity. Testosterone better predicted PCOS status compared to 11-oxyandrogens (receiver operating characteristic curve analysis: 11-OHA4 area under the curve [AUC] = 0.620, 11-OHT AUC = 0.638; testosterone AUC = 0.840). Among untreated PCOS patients, all 3 11-oxyandrogens correlated with hirsutism severity. 11-KT (P = .039) and testosterone (P < .006) were lower in those on COCP treatment compared to untreated PCOS. Metformin treatment had no effect on 11-oxyandrogens, although testosterone was lower (P = .01).
Conclusion
Although 11-oxyandrogens do not aid in the diagnosis of PCOS, they relate to excess hair growth. COCP treatment may related to 11-KT; however, further work is needed to determine causality, relationship with metabolic outcomes, and the clinical utility of measuring these androgens in PCOS.